Aims/hypothesis Microangiopathy is a leading complication of diabetes that commonly affects the retina. Degenerate capillaries are a central feature of diabetic retinopathy. An inflammatory process has been linked to the development of diabetic retinopathy but its regulation is incompletely understood. Cluster of differentiation (CD) 40 is a member of the TNF receptor superfamily that promotes the development of certain inflammatory disorders. The role of CD40 in diabetic microangiopathy is unknown. Methods B6 and Cd40 − / − mice were administered streptozotocin to induce diabetes. Leucostasis was assessed using fluorescein isothiocyanate-conjugated concanavalin A. Retinal Icam1 and Cd40 mRNA levels were examined using 
Introduction
Diabetic retinopathy is the leading cause of vision loss among working-age adults in developed countries. Important features of early vascular lesions of diabetic retinopathy include increased death of retinal endothelial cells and pericytes [1] . The transformation of capillaries into tubes of basement membrane devoid of cells (capillary degeneration) is relevant because degenerate retinal capillaries lack blood flow and, thus, likely contribute to retinal ischaemia and subsequent neovascularisation.
Increasing evidence indicates that a chronic low-grade inflammatory response plays an important role in the pathogenesis of diabetic retinopathy [2] . The number of leucocytes adherent to vessel walls is increased in the retinal vasculature during diabetes, a phenomenon mediated by upregulation of intercellular adhesion molecule 1 (ICAM-1) [3] . Blockade of the interaction between ICAM-1 and cluster of differentiation (CD) 18 diminishes capillary degeneration [4] . Inducible nitric oxide synthase 2 (NOS2) is expressed in the retinas of patients with diabetic retinopathy and in those of rat models of diabetes [5, 6] . Moreover, diabetic Nos2 −/− mice have diminished retinal leucostasis and capillary degeneration [7, 8] . While these represent significant advances in understanding the pathogenesis of diabetic retinopathy, the mechanisms that regulate these mediators of disease are not well understood.
Although the pathogenesis of diabetic retinopathy is complex, discovery of an upstream molecule that controls these proinflammatory responses may enhance the possibility of finding effective approaches for the prevention and management of diabetic retinopathy. CD40, a TNF receptor superfamily member, is expressed on various haematopoietic and non-haematopoietic cells [9, 10] . CD154 (CD40 ligand) is present on activated CD4 + T cells and platelets, and in plasma [9] . CD40-CD154 interaction not only regulates cellular and humoral immunity [9] but also activates inflammation. Indeed, CD40-CD154 signalling promotes atherosclerosis, graft rejection and various autoimmune disorders [11] . In vivo blockade of this pathway controls these diseases [11, 12] . Thus, the CD40-CD154 pathway is a target in the fight against various disorders in humans.
We explored the role of CD40 in the development of a microvascular complication of diabetes. We chose a model of retinopathy, since we reported that CD40 is constitutively expressed on retinal endothelial cells, microglia and Müller cells, the main glia of the retina [13] . In addition, plasma CD154 levels are increased in patients with diabetic retinopathy [14] . Real-time quantitative PCR cDNA was used as a template for real-time PCR using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and primers for ICAM-1 [15] , CD40 [16] or 18S rRNA [15] . Expression of these genes was assessed using a 7300 Real-Time PCR System (Applied Biosystems). Each cDNA sample was run in duplicate. Samples were normalised according to the content of 18S rRNA.
Methods

Induction of diabetes in mice
Leucostasis Fluorescein-coupled concanavalin A lectin (20% g/ml in PBS; Vector Laboratories, Burlingame, CA, USA) was infused as described [4, 17] . Retinal flat-mounts were viewed blindly via fluorescence microscopy, and brightly fluorescent leucocytes were counted in the entire retina.
Vascular histopathology
Retinal vasculature was isolated as described with minor modifications [17] . Eyes were fixed with 10% neutral buffered formalin followed by dissection of the retina. Retinas were incubated with elastase (40 U/ml; Calbiochem, San Diego, CA, USA Flow cytometry Retinas from each mouse were pooled and cell suspensions were obtained for flow cytometry as described [13] . Retinas were digested with papain (15 IU/ml)/DNAse (15 μg/ml; Worthington Biochemicals, Freehold, NJ, USA). Tissue was passed through a 40 μm cell strainer. Tissue trapped by the strainer was digested with collagenase type I (1 mg/ml; Worthington Biochemicals) to free endothelial cells. Cells obtained after papain/DNase and collagenase treatment were pooled. Cell suspensions that were >90% unicellular and with cell viability >90% were incubated with anti-CD11b (eBioscience, San Diego, CA, USA), anti-CD31 (eBioscience), anti-thymus cell antigen 1 (Thy-1) (to detect ganglion neurons; eBioscience) or isotype control Abs. Immunoblot Membranes were probed with Ab to ICAM-1 (Santa Cruz Biotechnologies), NOS2 (BD Biosciences) or actin (Santa Cruz Biotechnologies), followed by incubation with secondary Ab conjugated to horseradish peroxidase (Santa Cruz Biotechnologies). Intensities of ICAM-1 were calculated using ImageJ (NIH) and normalised against actin.
Measurement of nitrite production Nitrite concentrations were calculated using Griess reaction (Promega, Madison, WI, USA).
Statistical analysis All results are expressed as the mean ± SEM. Statistical significance of in vitro experiments was analysed by two-tailed Student's t test or ANOVA. In vivo experiments were analysed using the non-parametric KruskalWallis test followed by the Mann-Whitney U test. Differences were considered statistically significant at p<0.05.
Results
Diabetic Cd40
− [2, 7] . Unless otherwise stated, animals were examined at 2 months of diabetes to assess expression of pro-inflammatory molecules and leucostasis, or at 8 months of diabetes to examine vascular histopathology. Compatible with a low-grade chronic inflammation, leucocyte adhesion to the retinal vasculature (leucostasis) is increased in retinal vessels in diabetic animals [4, 22] . The retinal microvasculature of diabetic B6 mice exhibited the expected significant increase in the number of adherent leucocytes compared with non-diabetic mice (Fig. 1 ). Diabetic Cd40 −/− mice had a significant reduction in the number of adherent leucocytes compared with diabetic B6 animals ( Fig. 1) . Next, we determined whether CD40 is required for ICAM-1 upregulation in the retinas of diabetic mice. We examined Icam1 mRNA levels, since ICAM-1 expression is controlled at the mRNA level [23] . mRNA levels of Icam1 were similar in nondiabetic B6 and Cd40 −/− mice (Fig. 2) . Diabetic B6 mice upregulated mRNA levels of Icam1 in the retina (Fig. 2) , as reported in diabetic rodents [24] . By contrast, Icam1 upregulation was significantly impaired in diabetic Cd40 −/− mice (Fig. 2a) . Similar results were observed when ICAM-1 protein expression was examined in retinal lysates (Fig. 2b) . We also examined ICAM-1 protein expression at 6 months of diabetes. Whereas diabetic B6 mice exhibited a 2.5±0. CD40 is upregulated in the retina of diabetic mice CD40 upregulation is a common feature of diseases driven by CD40 [25] . To further explore the role of CD40 in diabetic retinopathy we examined CD40 expression in the retina. B6 mice that had been diabetic for 2 months exhibited increased Cd40 mRNA levels compared with non-diabetic controls (Fig. 3) . Next, we examined CD40 protein expression at a cellular level. Flow cytometry effectively quantifies upregulation of molecules in primary retinal cells in retinal inflammation [13] . We obtained retinal cell suspensions from non-diabetic and diabetic B6 mice and examined CD40 expression by flow cytometry. CD40 is expressed in various non-leucocytes at levels that are typically low but nevertheless functional [9, 26] . Confirming our previous report [13] , retinal endothelial cells, Müller cells, microglia and ganglion neurons expressed CD40 under basal conditions (Fig. 4) [27] . Ganglion neurons (Thy-1 + ) did not exhibit a significant increase in CD40 expression (Fig. 4) (Fig. 6 ).
CD40 promotes nitration of retinal proteins and upregulates NOS2 and nitric oxide production by Müller cells
Increased production of peroxynitrate results in nitration of tyrosine; thus, detection of nitrotyrosine is a marker of nitrosative stress in the diabetic retina. Nitrotyrosine expression is increased in the retinas of humans and rodents with diabetes [6, 8, [28] [29] [30] . This increase has been proposed to occur at the level of the retinal vasculature and is detected more intensely in the inner retina [6, 8, [28] [29] [30] . Moreover, increased nitrotyrosine expression persists for several months in the retina of diabetic rodents [31] . Retinas from B6 mice that had been diabetic for 2 or 8 months revealed increased staining for nitrotyrosine mainly in the innermost portion of the retina ( Fig. 7a ; and data not shown). By contrast, diabetic Cd40 −/− mice showed diminished staining for nitrotyrosine (Fig. 7a, b) . Müller cells from patients with diabetic retinopathy appear to express NOS2 [5] . We determined whether CD40 ligation affects NOS2 expression and production of nitric oxide by Müller cells. Primary human Müller cells upregulated NOS2 in response to stimulation with CD154 (Fig. 8a) . Incubation with a stimulatory anti-CD40 mAb upregulated NOS2 in a mouse Müller cell line (Fig. 8b) and caused increased nitrite production (Fig. 8c) . Similar results were obtained when mouse Müller cells were incubated with mouse CD154 (data not shown). Taken together, CD40 drives retinal protein nitration in vivo and causes Müller cells to upregulate NOS2 and produce nitric oxide, which are responses linked to the development of diabetic retinopathy. 
Diabetic Cd40
−/− mice are protected against retinal vascular degeneration Loss of endothelial cells and pericytes with resulting formation of degenerate capillaries is a key feature of diabetic retinopathy. We examined whether CD40 promotes the development of capillary degeneration. At 8 months of diabetes, B6 diabetic mice exhibited the expected significant increase in the number of degenerate capillaries and pericyte 'ghosts' (a marker of loss of pericytes) compared with non-diabetic animals (Fig. 9) . By contrast, diabetic Cd40 −/− mice did not develop capillary degeneration or pericyte loss (Fig. 9) . Thus, CD40 is important for the development of signature vascular features of diabetic retinopathy. Our demonstration that CD40 promotes in vivo and in vitro upregulation of ICAM-1 and leucostasis may explain why Cd40 −/− mice are protected from capillary degeneration. However, it has been suggested that leucostasis may not solely explain capillary degeneration. While diabetic mice deficient in 5-lipoxygenase exhibited diminished leucostasis and were protected from capillary degeneration, animals deficient in 12-lipoxygenase showed no reduction in capillary degeneration despite ablation of leucostasis [22] . Thus, there may be additional mechanisms besides leucostasis by which CD40 promotes vascular injury. Other mediators that promote retinal capillary degeneration in diabetes include NOS2 and oxidative stress [7, 32] . We report that CD40 stimulates NOS2 upregulation as well as nitric oxide production by retinal Müller cells, and CD40 is reported to upregulate nitric oxide production by microglia [33] . Moreover, CD40 ligation can stimulate production of reactive oxygen species [34] . Whether nitrosative and/or oxidative stress contributes to the role of CD40 in ICAM-1 upregulation remains to be determined. Müller cells in diabetes exhibit disrupted homeostatic functions, upregulate pro-inflammatory cytokines and acquire a reactive phenotype (GFAP upregulation) [35, 36] . In addition, NOS2 appears to be expressed in Müller cells from patients and animals with diabetic retinopathy [5, 6] . The mechanisms that explain Müller cell dysfunction in diabetes remain poorly understood. The breakdown of the blood-retinal barrier detected in diabetes raises the possibility that CD154 could interact with CD40 + Müller cells. We report that CD40-stimulated Müller cells upregulate NOS2, produce nitric oxide and upregulate ICAM-1. Of potential relevance to CD40-induced ICAM-1 upregulation on Müller cells is the report that retinas from patients with diabetic retinopathy exhibit ICAM-1 upregulation throughout the retina [37] .
Peroxynitrate production is associated with accelerated neuronal death in diabetic retinopathy [28, 30] . Our studies indicate that CD40 drives protein nitration in the diabetic retina, raising the possibility that CD40 may promote retinal neurodegeneration in diabetes. Indeed, in a mouse model of retinopathy induced by ischaemia/reperfusion, Cd40 −/− mice exhibited diminished loss of ganglion cells [15] . Our in vitro studies also suggest that Müller cells are involved in the protein nitration driven by CD40 in the diabetic retina. However, it is likely that CD40 promotes nitrosative stress by also acting on other cells. CD40 is expressed on retinal microglia [13] , which appear to become activated in diabetic retinopathy [38] . Moreover, CD40 upregulates NOS2 and nitric oxide production by microglia [33] . The CD40-CD154 pathway is likely activated in diabetes. Our studies revealed that CD40 is upregulated on retinal endothelial cells, Müller cells and microglia of diabetic mice. There is evidence that CD154 is increased in diabetes. Membrane CD154 on activated platelets triggers pro-inflammatory responses in endothelial cells [39] . The evidence for microthrombosis in the retinal capillaries of patients and animals with diabetic retinopathy [40] suggests the existence of increased local levels of CD154. CD154 also exists as a biologically active soluble homotrimer released primarily by activated platelets [41] . The levels of soluble CD154 in the circulation are increased in diabetic individuals, especially those with microangiopathy [14, 42, 43] . Moreover, serum Same-size regions were drawn on anatomically matched areas of the retina (six fields per section). Signal intensity was determined as described in the Methods section and given an arbitrary score of 1 for non-diabetic B6 mice (ten mice per group). GCL, ganglion cell layer; INL, inner nuclear layer. **p<0.01 CD154 from diabetic individuals induces pro-inflammatory responses in endothelial cells and monocytes [43] . Thus, there is not only increased CD40 expression in the retina in diabetes but also a likely local and systemic source of CD154 that can drive CD40-dependent responses in the retina during diabetes.
Of likely relevance to diabetic retinopathy, there is crosstalk between CD40 and TNF-α/IL-1β. CD40 cooperates with IL-1β for chemokine production by endothelial cells [15] , and CD40 and TNF-α synergise to upregulate NOS2 in macrophages [44] . CD40 enhances TNF-α and IL-1β production [45] , and TNF-α and IL-1 can increase CD40 expression [26] . While CD40 may act in concert with TNF-α and IL-1 in the development of diabetic retinopathy, our studies indicate that deletion of CD40 is sufficient to blunt the development of this disease.
In summary, these studies indicate an important role of CD40 in the development of microvascular complications of diabetes. Given that targeting a single molecule (CD40) would impair the activation of many mediators of this disease, this work suggests that the levels of glycaemic control achieved with current treatment for diabetes plus approaches to inhibit CD40 signalling may result in improved management of diabetic retinopathy.
